Reimbursement prices of new, innovative medicines in Germany: a comparison of negotiation and cost-effectiveness analysis
Artículo
Acceso abierto
Artículo
DOAJ
This study aimed to compare reimbursement prices for new, innovative non-orphan drugs in Germany based on price negotiation and cost-effectiveness analysis, using the efficiency frontier (EF) approach and cost-utility an...
LCC LCC:Public aspects of medicineIdioma eng
Acceso abiertoRuta libre sin proxy. Acceso recomendado cuando no hay suscripción activa.
Open Access